Personalization has gained considerable allure in consumer markets, and the beauty sector has embraced it with particular enthusiasm. Over the past ten years or so, many cosmetic companies have moved beyond the classic one-size-fits-all model, developing products and routines adapted to declared skin types, individual concerns, lifestyles, or demographic factors. Questionnaires, digital skin scanners, and recommendation algorithms now give consumers the impression of truly bespoke solutions.

Yet these early efforts at customization still depend largely on what can be seen or self-reported. Two individuals classified with the same “oily” or “sensitive” skin can differ profoundly in how their skin actually behaves, owing to distinct genetic backgrounds, cumulative environmental exposures, and personal circumstances. Skin physiology is influenced by genetic makeup, chronological age, hormonal fluctuations, ethnic background, together with external factors such as ultraviolet radiation, air pollution, dietary patterns, psychological stress, and everyday habits. Such diversity helps explain why generic formulations and categorizations can be inadequate for some consumers (1).

Precision skincare takes inspiration from the broader precision medicine movement — an approach that has already demonstrated, within dermatology itself, that matching treatments to individual molecular profiles can improve outcomes beyond what standard protocols allow — in an effort to overcome these constraints. It brings together biological, environmental, and behavioral data in pursuit of a far more detailed picture of an individual’s skin. Thanks to rapid advances in high-throughput sequencing, multi-omics technologies (genomics, proteomics, metabolomics, and microbiome profiling) along with improved imaging modalities and artificial intelligence, scientists and clinicians can now examine skin biology with a depth that would have seemed impossible only a brief time ago. The emphasis moves away from simply addressing visible features or broad skin-type labels toward the identification of distinct molecular profiles. These signatures, in turn, hold promises for more accurate forecasts of individual requirements, better matching of ingredients, and improved predictions of how skin might respond to specific treatments (2, 3).

The field is still emerging, surely representing an intriguing intersection of skin biology, computational science, and cosmetic formulation. However, translating this vision into everyday practice will require overcoming notable scientific, technical, regulatory, and ethical barriers before precision skincare can evolve into a fully mature and universally accessible approach.

Two people do not have exactly the same skin, even if they share the same age, gender, or ethnic background. Among healthy individuals, wide differences exist in how strong the skin barrier is, how well it holds moisture or how much oil it produces, if it easily becomes inflamed, the way pigment is distributed, and how quickly signs of aging appear. These differences arise from the lifelong conversation between a person’s genes and everything their skin has encountered along the way (430816-7/fulltext)).

Genetics certainly lays important groundwork. Variants in genes involved in pigmentation pathways (such as MC1R or IRF4), antioxidant defense, epidermal barrier formation, and collagen metabolism can significantly influence how skin reacts to sunlight, its tendency toward dark spots, sensitivity, or premature wrinkling. Still, genes rarely tell the full story. What is actually seen on the skin depends heavily on how those genes are expressed and that expression is continuously shaped by a person’s environment and daily habits (1, 5).

This is where the concept of skin exposome comes in. It covers the entire collection of non-genetic exposures we accumulate over a lifetime: ultraviolet and visible light, air pollution, cigarette smoke, eating and drinking habits, sleep, stress, climate conditions, and even workplace exposures. These factors can drive oxidative stress, shift inflammatory pathways, weaken the barrier, and speed up aging. In many cases, the cumulative effect of these exposures appears to explain more of the visible aging than the simple passing of years (430816-7/fulltext)).

The result is a highly personal and constantly shifting skin phenotype. Getting a real handle on this interplay feels like a necessary first step to move from non-specific skincare formulas to actually design approaches that respect each person’s unique biology.

One powerful way to capture this complexity is through omics technologies, which have quietly transformed skin research. Instead of studying one molecule or pathway at a time, scientists can now analyze thousands of biological signals simultaneously, opening new questions that were previously impossible to address (6).

Genomics provides the foundation. Variants across the genome have been associated with meaningful differences in pigmentation, antioxidant capacity, and aging trajectories. These associations reveal the underlying architecture of individual skin biology, why subjects exposed to the same environment can age or respond so differently to the same ingredient (1).

The transcriptome adds a dynamic layer. Because gene expression changes in response to internal and external signals, transcriptomic analysis can detect early signs of inflammation, oxidative stress, or matrix remodeling before they become visible, making it especially useful for understanding the molecular progression of skin aging (7).

Proteomics shifts the focus to functional biology. Proteins execute most biological processes like building tissue structure, regulating inflammation, and driving enzymatic activity. Unlike the genome or transcriptome, the proteome reflects what is actually occurring in the skin at a given moment (8).

Metabolomics, in turn, captures real-time biochemical activity. The small molecules it measures respond quickly to diet, stress, pollution, and microbial changes, offering a sensitive snapshot of oxidative balance, lipid metabolism, and inflammatory status (9).

The skin microbiome also deserves special attention. Modern sequencing has shown how dramatically microbial composition varies between individuals, body sites, and health states. Dysbiosis has been linked to acne, atopic dermatitis, and rosacea, encouraging the development of cosmetics that support rather than depleting the resident microbial communities (10, 11).

Yet no single omics layer tells the full story. The greatest insight comes from integrating genomic, transcriptomic, proteomic, metabolomic, and microbiome data with clinical and environmental information. This systems biology approach forms the true foundation of precision skincare (7).

Making sense of this biological complexity requires more than laboratory techniques alone. In parallel with the omics revolution, digital tools have advanced rapidly — and the two are increasingly being designed to work together.

Skin assessment technologies have come a long way. Modern high-resolution imaging systems can measure wrinkles, pigmentation changes, pore size, and surface texture with an objectivity and consistency that simple visual inspection rarely achieves. Smartphone applications have taken this further, bringing reasonably sophisticated analysis into everyday use and allowing both consumers and professionals to monitor skin changes over time under real-life conditions (12).

Beyond imaging, the integration of real-time environmental and lifestyle data is gaining traction. By combining genetic profiles with information on UV exposure, pollution levels, hydration status, and behavioral factors such as sleep patterns and stress, researchers are developing dynamic virtual models — often referred to as digital twins — of an individual’s skin. These evolving digital representations create a much richer, more predictive picture of the factors shaping skin health over time (2).

Of course, this wealth of information brings its own difficulties. The datasets are vast and multidimensional, but this is precisely where artificial intelligence, and machine learning can help. Indeed, these tools should not replace expert judgment, but they can help uncovering subtle patterns and connections that might otherwise remain hidden. Well-trained models can help identify meaningful relationships across complex data and support better grouping of individuals according to their biological and environmental profiles (12).

In this sense, the use of AI in skincare is still maturing. Although the models keep getting better, it is essential to also consider the quality and diversity of the data on which they are trained. Many current datasets suffer from limited ethnic and skin-type diversity, which can lead to algorithmic bias and reduced accuracy for certain populations (12).

What this points toward is a model where AI functions less as an oracle and more as an interpreter, one that becomes genuinely useful as the data it draws on becomes richer, more diverse, and more rigorously validated. The technology is ready to move fast; the science around it needs to keep pace.

Several applications have already begun taking shape in the cosmetics market, even if most works remain in progress. The most visible examples are personalized recommendation platforms — L’Oréal’s SkinConsult AI and Proven Skincare among them — which combine questionnaire data and skin imaging to move beyond generic advice and suggest products more closely matched to an individual’s actual profile. Some have shown encouraging results in reducing the familiar cycle of trial and error, and digital platforms are increasingly incorporating real-time environmental data to offer recommendations that shift as external conditions change (12, 13).

Further along the development pipeline, early experiments with AI-assisted compounding and 3D-printed cosmetic products are beginning to appear in the peer-reviewed literature (14), including personalized under-eye patches whose geometry and formulation can be adapted to both the user’s anatomy and their preferences (15). These remain niche and proof-of-concept, but they point toward the direction of travel.

Looking further ahead, the convergence of AI, omics data, and advanced manufacturing raises important questions about how personalized cosmetics might eventually be produced. On-demand or small-batch production formulas continuously adjusted to reflect changes in a person’s biology or environment — these are not yet realities, but they are logical extensions of where science is heading. Turning them into viable products will require robust clinical validation, workable regulatory frameworks, and production costs that do not confine precision skincare to a luxury niche.

Precision skincare is undeniably exciting. Yet, as is often the case with promising new fields, enthusiasm is running ahead of solid evidence.

Starting with the most important question: does true personalization actually deliver meaningfully better results? This is still surprisingly difficult to answer. While matching products to someone’s biology makes sense in theory, strong clinical proof that these approaches outperform conventional skincare remains scarce for most products currently on the market. Building reliable evidence will require long-term, well-designed studies that include genuinely diverse populations (2).

Data privacy is another real concern. These systems gather quite sensitive material, like facial images, social information, and sometimes genetic data. In Europe, this brings them under strict GDPR rules and potentially the AI Act, especially when the tools start edging into diagnostic territory (16).

The problem of algorithmic bias is equally serious. Most AI models in dermatology have been trained on datasets heavily dominated by lighter skin phototypes, which can reduce accuracy and fairness for many populations (12, 17). Addressing this will require deliberate efforts to diversify training datasets from the very beginning.

Finally, accessibility remains a significant concern. Advanced precision technologies are expensive to develop and deploy, raising the risk that their benefits will primarily reach higher-income consumers (2, 18).

Precision skincare is, at its core, a bet on specificity — that understanding a person’s genetics, microbiome, environment, and lifestyle in enough detail will eventually allow the industry to do far better than a generic moisturizer or a broad skin-type quiz. The tools are arriving, and some early applications are already meaningful.

But the honest picture is more complicated. Clinical evidence is still catching up with commercial enthusiasm. Datasets remain too narrow, regulatory frameworks too slow, and access too unequal for precision skincare to claim, yet, that it delivers on its promise for everyone. Algorithmic bias, data privacy, and the temptation to overstate what science can support are not peripheral concerns, but they sit at the center of whether this field earns lasting credibility.

What precision skincare could become, if it gets the fundamentals right, is a deeper understanding of skin as a dynamic biological system. Whether the field gets there will depend less on the sophistication of its technology than on the rigor and honesty it brings to science.

References and notes

1. Geusens, B. and Haykal, D. (2025) ‘Genetic profiling and precision skin care: a review’, Frontiers in Genetics. https://doi.org/10.3389/fgene.2025.1559510
2. Haykal, D. et al. (2025) ‘Cosmetogenomics unveiled: a systematic review of AI, genomics, and the future of personalized skincare’, Frontiers in Artificial Intelligence, 8, 1660356. https://doi.org/10.3389/frai.2025.1660356
3. Tan, I.J. et al. (2024) ‘Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies’, Current Issues in Molecular Biology, 46(4), pp. 2975–2990. https://doi.org/10.3390/cimb46040186
4. Krutmann, J. et al. (2017) ‘The skin aging exposome’, Journal of Dermatological Science, 85(3), pp. 152–161. https://doi.org/10.1016/j.jdermsci.2016.09.015
5. Jacobs, L.C. et al. (2015) ‘A genome-wide association study identifies the skin color genes IRF4, MC1R, ASIP, and BNC2 influencing facial pigmented spots’, Journal of Investigative Dermatology, 135(7), pp. 1735–1742. https://doi.org/10.1038/jid.2015.62
6. Dessì, A. et al. (2024) ‘Integrative multiomics approach to skin: The synergy between individualised medicine and futuristic precision skin care?’, Metabolites, 14(3), 157. https://doi.org/10.3390/metabo14030157
7. Long, B. et al. (2025) ‘Advances in the application of multi-omics analysis in skin aging’, Frontiers in Aging, 6, 1596050. https://doi.org/10.3389/fragi.2025.1596050
8. Fredman, G. et al. (2022) ‘Towards precision dermatology: Emerging role of proteomic analysis of the skin’, Dermatology, 238(1), pp. 12–23. https://doi.org/10.1159/000516764
9. Masutin, V. et al. (2022) ‘A systematic review: metabolomics-based identification of altered metabolites and pathways in the skin caused by internal and external factors’, Experimental Dermatology, 31(7), pp. 1048–1062. https://doi.org/10.1111/exd.14529
10. Hong, J.Y. et al. (2025) ‘Microbiome-based interventions for skin aging and barrier function: A comprehensive review’, Annals of Dermatology, 37(5), pp. 259–268. https://doi.org/10.5021/ad.25.009
11. Condrò, G. et al. (2022) ‘Acne vulgaris, atopic dermatitis and rosacea: The role of the skin microbiota — A review’, Biomedicines, 10(10), 2523. https://doi.org/10.3390/biomedicines10102523
12. Hash, M.G. et al. (2025) ‘Artificial intelligence in the evolution of customized skincare regimens’, Cureus, 17(4), e61578. https://doi.org/10.7759/cureus.82510
13. ‘Climate-adaptive beauty: Real-time adaptation, stress ‘training’ for skin, clean credibility, multi-stress protection and more’ (2025) Cosmetics & Toiletries.
14. Landau, M., Tsoukas, M. and Goldust, M. (2025) ‘3D-printed cosmetic enhancements guided by artificial intelligence’, Journal of Cosmetic Dermatology, 24(6), e70263. https://doi.org/10.1111/jocd.70263
15. Bom, S., Pinto, P.C., Ribeiro, H.M. and Marto, J. (2025) ‘Digital tools in action: 3D printing for personalized skincare in the era of beauty tech’, Cosmetics, 12(4), 136. https://doi.org/10.3390/cosmetics12040136
16. Di Guardo, A. et al. (2025) ‘Artificial intelligence in cosmetic formulation: Predictive modeling for safety, tolerability, and regulatory perspectives’, Cosmetics, 12(4), 157. https://doi.org/10.3390/cosmetics12040157
17. Joerg, L. et al. (2025) ‘AI‐generated dermatologic images show deficient skin tone diversity and poor diagnostic accuracy: An experimental study’, Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20849
18. Fritzsche, M.C., Hangel, N. and Buyx, A.M. (2025) ‘Ethical challenges in biomarker research and precision medicine – a qualitative study in dermatology’, BMC Medical Ethics, 26(1), 162. https://doi.org/10.1186/s12910-025-01258-6

Explore the article in the digital edition